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Apoptosis, which is one of many different types of programmed cell death, is widely utilized as a 
mechanism to eliminate unwanted cells.  The ability of cells to undergo apoptosis is required not 
only for development in many organisms, but also to maintain proper homeostasis; too little 
apoptosis can result in cancer whereas too much can lead to degenerative diseases. Apoptosis has 
been well studied at events that take place at or downstream of the mitochondria; these steps are 
rigorous and predictable, making them easy to study. However, little is known about early, 
decision-making events that occur upstream of the mitochondria. It is important to understand 
these early decision-making steps because it is at these timepoints when cells are not yet 
committed to live or die, and therefore have great potential for therapeutic intervention. 
We have identified a novel ARTS-dependent complex that forms extremely early in apoptosis. 
After inducing mammalian cells to die, we fractionated the cell extracts using gel filtration and 
looked for changes in canonical apoptosis proteins. We observed that XIAP, the main caspase 
inhibitor in mammals, is recruited to a 5Mda complex as early as 30 minutes after stimulation of 
apoptosis. Furthermore, the recruitment of XIAP to the complex is dependent on the pro-
apoptotic protein ARTS, as XIAP is not recruited to the complex when cells are knocked out for 
ARTS.  
Using mass spectrometry, we have identified the constituents of the complex. The identified 
subunits are Herc2, Neurl4, SSSCA1 and XIAP. None of the identified subunits, aside from 
XIAP, have been previously implicated in apoptosis. Using cell culture assays, we have shown 
that the novel complex acts to degrade XIAP, thus shifting the propensity of cells to undergo 
apoptosis early on in the decision-making process. We have shown that knocking down Neurl4 
leads to the stabilization of XIAP during apoptosis and, consequently, reduces the number of 
cells that undergo apoptosis. The identification and elucidation of this novel complex in 
apoptosis not only increases our basic understanding of apoptosis, but also provides new 
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CHAPTER 1: INTRODUCTION 
We live in a dynamic world where life is constantly being challenged and requires continuous 
adaptation. Consequently, organisms have evolved myriad ways to respond to an ever-changing 
environment. A process fundamental for proper fitness in higher organisms is apoptosis, which is 
a type of programmed cell death that is utilized throughout life, from development to coping with 
stresses. The precise and faithful regulation of apoptosis is paramount; too much apoptosis can 
result in degenerative diseases whereas too little can result in autoimmune diseases and cancer. 
Our understanding of apoptosis has come a long way since it was first observed in 1842, and as 
we continue to learn about it, we will be presented with new therapeutic opportunities to better 
treat many diseases. 
Apoptosis is an active process characterized by distinct morphological changes, such as cell 
shrinkage, chromatin condensation, retained membrane integrity and inversion of the cell 
membrane (Jacobson, Weil, & Raff, 1997). These changes are not seen in passive cell death, 
termed necrosis, which results in the cell swelling and ultimately rupturing. Apoptosis is used to 
eliminate cells which have received stimuli to die, such as extensive DNA damage, viral 
infection or hormonal signals. The current consensus is that the regulation of apoptosis largely 
takes place at the mitochondria, where pro-apoptotic proteins are being continuously inhibited by 
anti-apoptotic proteins. Once pro-apoptotic proteins overwhelm their anti-apoptotic counterparts, 
the mitochondria undergo mitochondrial outer membrane permeabilization (MOMP), releasing 
several pro-apoptotic factors such as cytochrome C, a so-called point of no return where cells are 





Figure 1.1: The core apoptotic pathway in C. elegans, Drosophila Melanogaster and Mammals. 
Apoptosis has been extensively studied in many organisms. However, most of what we know 
about apoptosis occurs either at or downstream of the mitochondria. The aim of this thesis is to 
understand events that take place during the decision-making phase of apoptosis, which is 
upstream of mitochondria permeabilization (Fuchs & Steller, 2011). 
 
One of the most upstream events of apoptosis is the sensing of cellular damage. The protein p53 
is a well-studied regulator of apoptosis that is known to detect intracellular damage. When p53 is 
activated, it translocates to the nucleus, where it activates the transcription of pro-apoptotic genes 
NOXA and PUMA (Oda, 2000; Nakano, 2001). The expression of Puma and Noxa induces 
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MOMP by activating Bax/Bak, which are pro-apoptotic Bcl-2 family members that form pores in 
the outer mitochondrial membrane (Oltvai, 1993; Farrow, 1995). MOMP then results in the 
release of pro-apoptotic mitochondrial factors into the cytosol, such as Smac/Diablo, Omi/HtrA2, 
AIF and cytochrome C (Du, 2000; Joza, 2001; Martins, 2001; Verhagen, 2000; Zou, 1997).  
After cytochrome C is released into the cytosol, it binds to Apaf1, causing its oligomerization 
and recruitment of Caspase-9 (Rodriguez, 1999; Xuan, 1992; Zou, 1997). The resulting complex 
is termed the apoptosome and its function is to activate Caspase-9 (Seshagiri, 1997). After 
Caspase-9 is activated, it is able to activate Caspase-3 by removing its pro-domain (Fernandes-
Alnemri, 1994; Nicholson, 1995). The activation of caspases is a critical step in inducing 
apoptosis. 
Caspases are cysteine proteases that are central downstream components of the apoptotic 
machinery. They contain inhibitory pro-domains and are activated when the pro-domain is 
cleaved off. Initiator caspases include Caspase-8 and 9 and are responsible for the activation of 
executioner caspases. Executioner caspases include caspases 3 and 7 and once activated, go on to 
cleave numerous substrates responsible for the apoptotic phenotype. Therefore, the tight 
regulation of caspases is critical in preventing aberrant cell death. 
Inhibitors of apoptosis (IAPs), as their name suggests, are an important class of proteins for 
putting the brakes on cell death. IAPs are able to directly bind caspases via their BIR domains. 
XIAP, which has been extensively studied among the IAPs, can inhibit initiator Caspase-9 as 
well as executioner Caspases 3 and 7, and serves as a threshold that must be overcome for 
apoptosis to continue (Deveraux, 1997). It is important to note that XIAP’s ability to bind 
caspases is not sufficient to block apoptosis; XIAP’s RING domain, which serves as an ubiquitin 
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ligase, is required for XIAP’s ability to inhibit caspases, and consequently, apoptosis in vivo 
(Joazeiro, 2000; Schile, 2008). Therefore, a critical step in carrying out apoptosis is the inhibition 
of XIAP. 
As mentioned earlier, Smac/Diablo and Omi/HtrA2 are two pro-apoptotic proteins that are 
released from the mitochondria after MOMP. Once released, Smac/Diablo and Omi/HtrA2 are 
thought to bind to and inhibit XIAP, which in turn liberates caspases for the induction of 
apoptosis (Du, 2000; Martins, 2001; Verhagen, 2000). In addition, there is evidence that the 
interaction of Smac/Diablo and Omi/HtrA2 with XIAP promotes the ubiquitination and 
degradation of XIAP (Fu, 2003). This loss of XIAP inhibition of caspases along with caspase 
activation marks the final steps in the apoptosis cascade. However, it is important to note that 
there is no in-vivo evidence that supports Smac/Diablo’s antagonistic role against XIAP or that it 
affects apoptosis in-vivo, since mice that are knocked out for Smac/Diablo do not have any 
apoptosis defects. These findings suggests that perhaps other pro-apoptotic factors are more 
important for the inhibition and degradation of XIAP. 
A pro-apoptotic protein that is known to be involved early in apoptosis is the Septin 4 splice 
variant ARTS (Larisch, 2000). ARTS, which is usually localized at the mitochondria, is found in 
the cytosol as early as 30 minutes following staurosporine treatment. It has also been shown that 
ARTS can directly bind to and antagonize XIAP (Bornstein, 2011; Gottfried, 2004). In addition, 
unlike the other XIAP antagonists, ARTS interacts with XIAP well before MOMP (Edison, 
2012). This suggests that ARTS is encouraging cell death very early in the apoptosis decision 
making process. Interestingly, ARTS has recently been implicated in stem cell apoptosis (García-
Fernández et al., 2010). In a mouse skin wound healing model, it has been shown that the 
number of hair follicle stem cells increases when ARTS is knocked out, and consequently, the 
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mice are able to heal quicker after wounding due to the increased number of stem cells (Figure 
1.2).  
 
Figure 1.2: ARTS and XIAP play a pivotal role in stem cell homeostasis and wound healing.  
ARTS and XIAP play an important role in the regulation of apoptosis, with a particularly 
significant role in stem cell homeostasis. In this study, mice that were either wild-type, ARTS 
knockout, XIAP knockout or ARTS XIAP double knockout were given puncture wounds in the 
skin and their healing analyzed. Interestingly, mice that were ARTS knockout had more stem 
cells, and consequently, were able to heal their wounds quicker. In contrast, mice that were 
XIAP knockout had fewer stem cells and their wounds initially worsened before recovering. 
Finally, ARTS XIAP double knockout mice had the same phenotype as the XIAP knockout, 
showing that ARTS regulates stem cells via XIAP. These data are exciting because they highlight 
the critical role ARTS and XIAP play in stem cell biology. WT: Wild Type; S/A: ARTS; SX; 
ARTS/XIAP (Fuchs et al., 2013). 
 
Knocking out XIAP in the ARTS deficient mice results in the opposite phenotype; the 
XIAP/ARTS double knockout mice have fewer stem cells and the wounds initially get larger,  
thus giving in vivo evidence that ARTS and XIAP have opposite functions in stem cell apoptosis 
(Fuchs, 2013). These recent in vivo stem cell findings are exciting because XIAP and ARTS 
have a more pronounced impact on apoptosis in these systems compared to their effect on 




KINETICS OF APOPTOSIS 
An intriguing observation of apoptosis is the fact that even within the same cell culture plate, 
cells can have significant variation in the time they take to undergo apoptosis, despite all 









Figure 1.3: The kinetics of apoptosis at single-cell resolution.  
When apoptosis is analyzed by western blot, it appears to be a predictable process with little 
variation; this is a result of western blots averaging an entire cell population. However, when 
using single-cell resolution, the temporal variation of apoptosis between cells becomes apparent. 
Mitochondrial outer membrane permeabilization (MOMP) is a committal step in apoptosis. After 
MOMP occurs, as is shown in panel A, the remaining apoptotic pathway becomes robust and 
predictable. However, large variation can exist in the time it takes individual cells to undergo 
MOMP, as shown in panel C. Although the majority of cells take around four hours to undergo 
MOMP, some cells can take as little as two hours or upwards of 20 hours, despite all of the cells 
receiving the exact same treatment. The goal of this project is to understand what accounts for 





Usually, the average of the entire cell population is studied by looking at protein changes via 
Westerns blots. By looking at the population average, one would be mislead into believing that 
apoptosis is a very gradual process with little variability. However, after looking at the kinetics 
of apoptosis with single cell resolution, one can see that there is a large kinetic variance that 
occurs between cells undergoing apoptosis. When given staurosporine or TRAIL, most cells will 
undergo MOMP in 3-4 hours; however, some cells in the plate will take up to 16 hours or even 
longer to undergo MOMP. In addition, the time it takes for MOMP and cytochrome C release 
can vary greatly based on the death-inducing stimulus. For example, it takes approximately 3-4 
hours for MOMP to occur when a cell is given staurosporine or TRAIL, compared to 14 hours 
for UV-induced death (Goldstein, 2005). Furthermore, it has been shown that stronger doses of 
UV induce apoptosis in cells quicker than weaker doses (Goldstein, 2000). Figure 1.3D shows 
the temporal variance that occurs between individual cells undergoing apoptosis, despite the fact 
that they are in the same dish. By studying early, decision-making events, we hope to give 










CHAPTER 2: MATERIALS AND METHODS 
Cell culture of human cancer cell lines 
HeLa and MCF7 cells were acquired from ATCC. ARTS knockdown HeLa cells were derived 
from the Larisch lab of Haifa University. The human cell lines were grown in DMEM containing 
10% FBS at 37 Celsius with 5% CO2. 
Cell culture of mouse keratinocytes and HFSCs 
Keratinocytes and HFSCs were obtained from WT, ARTS KO and XIAP KO mice. The protocol 
for harvesting the keratinocytes and HFSCs is as described by (Soteriou et al., 2016). The HFSCs 
and keratinocytes were grown in low calcium conditioned media provided by Elaine Fuchs’s lab 
and grown at 37 Celsius at 5% CO2.  
Generation of stable shRNA knockdowns in mouse keratinocytes 
Neurl4, XIAP, Herc2 and SSSCA1 were knocked down in keratinocytes using a lentiviral 
shRNA library provided by the Elaine Fuchs lab. The protocol for the lentiviral knockdown is 
described by (Beronja, Livshits, Williams, & Fuchs, 2010). 
siRNA knockdowns in human cancer cell lines 
The RNAiMAX kit from Thermo Fischer was used for the transfections of the siRNAs. In brief, 
the cells were incubated with 10nM of each siRNA for 24 hours and then used for assays.  
The siRNAs used are as follows: ARTS 5’ - GAGCACCAGGGGCAGGGCT - 3’; Apaf1 5’ – 
AATTGGTGCACTTTTACGTGA – 3’; Herc2 ON-TARGETplus Human HERC2 (8924) 
siRNA – Individual from Dharmacon; Neurl4 ON-TARGETplus Human NEURL4 (84461) 
10 
 
siRNA – Individual from Dharmacon; XIAP custom VC30002 XIAP siRNA from QIAGEN 
XIAP siRNA #5 sequence; SSSCA1 SASI_Hs01_00114866 SSSCA1 siRNA Rank 1 from 
Sigma Aldrich. 
Induction of apoptosis by STS, ETO and UV 
Apoptosis was induced in cells using varying concentrations of STS, ranging from 0.05-5uM. 
The STS was added directly to the cells by pipetting into the media. ETO was used at a 
concentration of 50uM and incubated for varying amount of time, ranging from 12-72 hours. 
Cells were induced to die with UV using the STRATALINKER 2000 crosslinker with 200uJ of 
UV. Cells would typically die after 12-24 hours after exposure.  
Collecting apoptotic cells for IP and gel filtration 
When cells were ready to be collected, the media would be collected and spun down to catch any 
detached cells. Then, the cells would be washed with PBS and trypsinized with 0.25% trypsin for 
5-10 minutes. The cells would then be added to the same tube containing their corresponding 
media and spun for 5 minutes at 800g. The cell pellet would then be washed with freeze-thaw 
lysing buffer (50mM PIPES, 50mM NaCl, 2mM EGTA, 1mM magnesium chloride) and spun 
again. Finally, the cells would be resuspended at a 1:1 ratio of freeze-thaw lysis buffer to pellet 
volume. The cells would then be lysed by freeze thaw: the cells would be flash frozen in liquid 
nitrogen for 30 seconds, then thawed in 9 Celsius water for a total of 3 freeze/thaws. The lysis 
would then be spun at 20,000g for 10 minutes at 4 Celsius. The supernatant would then be 





Cell lysates were fractionated using the following columns: Superdex 200 10/30GL, Sephacryl 
S500 100/300GL. The Akta Pure 25 HPLC system was used for gel filtration. All gel filtrations 
were done at 4 Celsius. The buffer used for gel filtration is: 50mM PIPES, 150mM NaCl, 2mM 
EDTA, 1mM magnesium chloride. 
IP and mass spectrometry 
Following gel filtration, the fractions containing the complex were identified by Western Blot. 
The fractions containing the complex were then pooled together into the same tube and IPed 
using magnetic DynaBeads covalently conjugated to antibodies. The antibodies used were: 
SSSCA1 ab117911 Anti-SSSCA1 antibody [2F5] from Abcam; Neurl4 PRX-MKA1787 from 
Cosmo Bio; Herc2 612366 from BD Transductions; ARTS monoclonal mouse from Sigma; 
XIAP clone 28 from BD Transductions. 
100ng of beads were used per 1ml of IP. The fractions were incubated with the beads for 4 hours 
at 4 Celsius while rotating. The beads were then washed 8 times with cold PBS and eluted with 
50ul of 8M urea. The 50ul eluate was then used for in-solution mass spectrometry and compared 
to the IP of fractions containing the 440kDa XIAP complex.   
Time lapse imaging of apoptosis 
For time lapse live imaging of cells, the incubator Fluffles microscope at the Rockefeller 
University Imaging Facility was used. To visualize apoptosis in real time, the cells were given 
the fluorescent caspase 3/7 indicator  CellEvent™ Caspase-3/7 Green Detection Reagent from 
Invitrogen. The protocol provided by the kit was followed. In addition, the cell nuclei were 
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stained using SiR-DNA (Cat. # CY-SC007) from Cytoskeleton. After the cells were induced to die, 
they were imaged for various amounts of time using a DIC objective for the cell body, a GFP 
objective for the caspase indicator and a Cy5 objective for the SiR-DNA signal. The number of 
apoptotic cells was determined by dividing the total number of green cells (caspase positive 
cells) by the total number of Cy5 positive cells (SiR-DNA Cy5 stains all cells regardless of 
apoptosis). 
Drosophila melanogaster wing disc experiments 
The wing discs from wandering third instar larva were dissected and treated with staurosporine 
in Schneider’s media. The wing discs were then fixed with 4% paraformaldehyde for 1 hour at 
room temperature. The fixed wing discs were then stained with Hoechst, anti-cleaved Caspase 3 












CHAPTER 3: XIAP IS RECRUITED TO A LARGE COMPLEX DURING APOPTOSIS 
Identifying proteins involved in the initiation of apoptosis 
Early events in the initiation of apoptosis are poorly understood. As mentioned earlier, the 
kinetics of apoptosis varies widely between individual cells. However, after MOMP, the 
execution and time frame of apoptosis becomes very robust and predictable, with little variation; 
all of the kinetic variance occurs upstream of MOMP. Therefore, in order to study apoptosis 
during these upstream, decision-making events, we decided to look for changes using gel 
filtration in canonical apoptosis proteins immediately after inducing cells to die with 
staurosporine (STS). 
Because it has been shown that ARTS is upregulated within 30 minutes of STS-treated cells, we 
looked for ARTS-dependent changes of other apoptosis proteins at similar time points. We 
discovered that a small portion (approximately 1%) of the total XIAP is recruited to a large 







Figure 3.1: A large XIAP-containing complex forms in the first 30 minutes of apoptosis. 
HeLa cells were treated with 1.75uM STS for 30 minutes and then lysed by freeze thaw. The 
soluble lysate fraction was run on a Superdex 200 gel filtration column. These data show that 
XIAP is recruited to a large complex 30 minutes after STS treatment and this recruitment is 
dependent on ARTS, since XIAP is not recruited to the complex in the ARTS knockdown cells. 
The apoptosome formation is also delayed in the ARTS knockdown cells, showing that ARTS, and 
perhaps XIAP’s recruitment to the large complex, is important for proper apoptosis initiation.  
 
Importantly, the knockdown of ARTS abrogates the recruitment of XIAP to the complex, 
suggesting that the recruitment of XIAP to this large complex is dependent on ARTS and 
specific to apoptosis. Furthermore, the knockdown of ARTS also delays the formation of the 
apoptosome (a complex containing Apaf-1), perhaps because the recruitment of XIAP to this 
complex might be a required step for downstream apoptotic events to occur properly. 
Elucidating the molecular size of the complex 
Although we observe XIAP being recruited to a large complex, the fractions that contain the 
complex are in the flowthrough of the initial column used. In other words, the size of the 
complex is beyond the upper resolution limit of the column. Therefore, in order to elucidate the 
actual size of the complex that XIAP is being recruited to, we shifted to a larger column. 
Repeating the same method using the larger column, we discovered that the complex XIAP is 
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being recruited to is approximately 5MDa in size. Specifically, we see that the complex XIAP is 
recruited to peaks at fraction 16, which is much larger than the proteasome (Rpt3), which is 
around 2MDa and peaks at fraction 22 (Figure 3.2). 
 
Figure 3.2: The large XIAP-containing complex is approximately 5MDa. 
HeLa cells were treated with 1.75uM STS for 30 minutes and then lysed. The soluble lysate 
fraction was run on a Sephacryl S500 gel filtration column.  (Top two panels) The fractions were 
then blotted for XIAP by western. (Lower panel) Chromatogram of lysate using absorbance at 
280nm. Because the first column (Superdex 200) used has a size resolution limit of 600kDa, we 
switched to a larger column and discovered that the complex XIAP is recruited to during 
apoptosis is approximately 5MDa. The red asterisk indicates the peak fraction containing the 
5MDa complex. The peak fraction that would contain the 26S proteasome (Rpt3) is marked to 
show where a 2MDa complex would elute on this column.  
 
After discovering that the molecular size of the complex is approximately 5MDa, we next 
wanted to test the complex’s stability in detergent. Because such a minute amount of total XIAP 
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is recruited to the complex, it would be useful to know whether detergent can increase the 
amount of the complex that can be recovered from the cell lysate. We added the mass 
spectrometry-compatible detergent PPS Silent Surfactant in varying quantities to the cell lysates 






Figure 3.3: PPS Silent Surfactant does not increase the yield of the complex during purification. 
HeLa cells were lysed by freeze thaw and treated with varying amounts of PPS Silent Surfactant. 
The supernatants of the lysates were then run on the sephacryl S500 gel filtration column. PPS 
Silent Surfactant did not affect the amount of the complex that could be obtained, nor did it 
disrupt the stability of the complex. These data suggest that the complex’s stability is resistant to 
detergent and detergent does not increase its solubility, since the amount of XIAP in the pellet 




Adding the detergent PPS Silent Surfactant did not increase the solubility of the complex and did 
not disrupt the stability of the complex as well. As can be seen in Figure 3.3, the vast majority of 
XIAP is in the supernatant, with very little in the pellet. However, it is unknown how much of 
the XIAP in the pellet is composed of the 5MDa apoptosis complex versus the 400kDa complex, 
which contains the vast majority of XIAP and is not apoptosis dependent. Since the pelleted-
XIAP was not affected by the PPS detergent, other methods, such as varying the salt 
concentration of the lysate, can be used to determine if the amount of pelleted-XIAP can be 
altered. 
Now that we have discovered the true size of the complex using the Sephacryl S500 column, we 
wanted to test if other canonical apoptosis proteins are eluting in the same fractions. The obvious 
candidate to test first is ARTS, since the formation of the complex is ARTS-dependent. 









Figure 3.4: ARTS is not detected in the 5MDa fractions. 
STS-treated HeLa cells were lysed and fractionated by gel filtration using the S500 column. We 
looked for the presence of ARTS in the 5MDa fractions (inside the vertical red lines) since the 
formation of the complex is ARTS-dependent. ARTS was not detected in the 5MDa complex, 
suggesting that ARTS is not physically bound to the complex, despite being involved in its 
formation. 
Although the formation of the 5MDa complex is dependent on ARTS, ARTS itself was not 
detected in the fractions containing the complex. This result suggests that ARTS is not physically 
associated with the complex. Alternatively, the association of ARTS with the complex could be 
extremely transient, resulting in levels of ARTS that are not detectable by Western Blot or that 
the association does not persist through the gel filtration procedure. Since ARTS was not 
observed to be physically bound to the complex, perhaps it acts as a chaperone to bring the 
various subunits of the complex together. Another explanation is that ARTS is necessary for 
post-translational modifications of the subunits in order to allow the formation of the complex.  
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Mass spectrometry is significantly more sensitive than Western Blots, so if ARTS is bound to the 
complex in quantities not detectable by Western Blot, it should be detectable by mass 
spectrometry. Mass spectrometry could also potentially tell us if the subunits of the complex are 
post-translationally modified compared to the unassociated subunits. However, mass 
spectrometry becomes more complex when looking for protein modifications and requires large 
quantities of the modified proteins, which is a problem given that the amount of the total XIAP 
in the complex is miniscule in comparison to the total XIAP. Therefore, we wanted to first look 
by Western Blot to determine if there are noticeable size shifts in XIAP compared to the 
unassociated XIAP to determine if XIAP is perhaps modified in the complex (Figure 3.5). 
 
Figure 3.5: XIAP appears to be post-translationally modified in the complex. 
STS-treated HeLa cells were lysed and fractionated by gel filtration using the S500 column. 
XIAP in the 5MDa fractions (outlined in the red rectangle) was then visualized by Western Blot. 
A ladder of increasing size of XIAP can be seen in the 5MDa fractions, showing that XIAP is 
post-translationally modified in the complex. The size of the XIAP ladder bands are 
approximately a few Daltons each, suggesting a large modification such as ubiquitination.  
Looking closely at XIAP in the 5MDa fractions, it does appear that XIAP is being post-
translationally modified. A ladder of increasing size of XIAP can be seen in the fractions 
containing the complex. The size increase of the modified XIAP is a few Daltons each, 
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suggesting a large modification, such as ubiquitination. Since ubiquitination is suspected, the 
next step would be to purify the complex by immunoprecipitation and blotting for ubiquitin to 
determine if the modification is indeed ubiquitin or some other modification. Importantly, the 
ladder must be due to a modification and is not due to breakdown of XIAP, since all of the steps 
of the ladder are above the endogenous size of XIAP (~55kDa). 
In addition to ARTS, we wanted to test whether other canonical apoptosis proteins could be 
found in the fractions containing the complex (Figure 3.6). Looking through the literature, we 




Using Table 3.1, we looked by Western Blot for validated XIAP interactors in the 5MDa 
fractions for which we had antibodies (Figure 3.6). 
Table 3.1: A list of all known XIAP interactors. 
We went through the literature of XIAP to compile a table of all validated interactors of XIAP. 
Most of the proteins were identified by large-scale proteomics studies. This table can be used to 





Figure 3.6: Co-elution of other canonical apoptosis proteins with the 5MDa complex. 
STS-treated HeLa cells were lysed and fractionated by gel filtration using the S500 column. We 
looked for the presence of various proteins in the 5MDa fractions (inside the vertical red lines) 
to search for potential subunits of the complex. None of the proteins analyzed co-eluted with the 
5MDa complex. 
None of the proteins we looked at co-eluted with the 5MDa complex. Some of the proteins are 
canonical apoptosis proteins, such as Caspase 9, BCL-2, ARTS and Apaf. Others, such as p97 
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and Drp1 are chaperones that could potentially be involved in the formation of the complex. 
Rpt3 is part of the proteasome and is a useful size marker, peaking in fractions approximately 
2.6MDa in size. In addition, due to the large size of the complex, we were interested to 
determine if the proteasome could be part of it and contribute to its large size. However, as was 
the case with all of the proteins tested so far, Rpt3 also did not co-elute with the 5MDa complex. 
Co-immunoprecipitation and identification of the complex by mass spectrometry. 
So far, the only known component of the complex is XIAP. To identify the other subunits, we 
co-IPed the complex from the Sephacryl S500 gel filtration fractions containing the complex 
with anti-XIAP antibody conjugated beads. As a control, we used beads conjugated to random 




Figure 3.7: The strategy used for the mass spectrometry experiment. 
STS-treated HeLa cells will be lysed and fractionated by gel filtration using the S500 column. 
The fractions containing the complex (outlined in red) will then be immunoprecipitated for XIAP 
and sent for mass spectrometry by both silver gel and solution. The results of both the silver gel 
and in-solution mass spectrometry should identify the subunits of the complex. The control for 
the mass spectrometry will be immunoprecipitation of the same fractions using purified mouse 
IgG antibodies. 
Before doing the mass spectrometry, we first have to validate the immunoprecipitation of XIAP 
and its elution by mass spectrometry-compatible methods. The two most common ways to elute 
protein from antibody for mass spectrometry are by using glycine and urea. We tested both 
methods to determine which one works better (Figure 3.8).  
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Figure 3.8: Validating the elution of the anti-XIAP IP by glycine and urea for mass 
spectrometry. 
STS-treated HeLa cells will be lysed and fractionated by gel filtration using the S500 column. 
The fractions containing the complex were then immunoprecipitated for XIAP (clone 48 
antibody) and eluted by the addition of either glycine pH 2.5 or urea. The glycine pH 2.5 
resulted in incomplete elution of XIAP from the antibody whereas the 8M and 6M urea fully 
eluted XIAP in a single elution. Therefore, urea is a much better method of elution when eluting 
XIAP from the clone 48 antibody compared to glycine. FT = flowthrough; E = elution. 
The glycine pH 2.5 did not fully elute XIAP from the antibody. In contrast, 8M and 6M urea 
fully eluted XIAP in a single elution. The upper limit of urea that is still suitable for mass 
spectrometry is 8M, which is the concentration we have decided to use for the mass spectrometry 
experiment. If neither the glycine or urea worked well, we would have to either use a different 
antibody for the IP or use a harsher method of elution, which usually results in higher noise.  
However, one method of elution that works well without producing more background noise is 
using a peptide competitor that competes with the protein binding interface of the antibody. In 
order to develop a peptide that can compete for the antibody, one must first identify the epitope 
on the protein that is recognized by the antibody. In addition for mass spectrometry, elution by  a 
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peptide competitor is useful for in vitro assays, as it does not disrupt or denature the proteins, 
thus preserving their function. Therefore, we aimed to identify the epitope of XIAP that is 
recognized by the antibody so that we could produce a peptide that can be used for elution 
(Figure 3.9). 
 
Figure 3.8: Determining the XIAP epitope that is recognized by the antibody. 
The peptide used to produce the antibody (anti-XIAP clone 48 by BD Transductions) maps to the 
UBA domain of XIAP. In order to find the exact epitope, we divided the immunogen peptide into 
six different fragments. We then cloned and purified each fragment and tested which of the six 
fragments could be immunoprecipitated by the antibody. We discovered that fragment five was 
able to bind to the antibody. The identified epitope can be used as a peptide competitor to elute 
XIAP from the antibody without denaturing proteins.  
The company that produces the antibody provided the peptide that was used to generate the 
antibody, which mapped to the UBA domain of XIAP. In order to make a precise peptide 
competitor, we divided the peptide into six fragments and tested which of the fragments could 
bind to the antibody. We discovered that the fifth fragment was able to be pulled down by the 
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antibody. The identification of this peptide provides us a way to elute XIAP and the complex 
from the antibody for in vitro functional assays that require the proteins to be in their native 
form. 
Mass spectrometry identification of the complex 
Moving forward with the mass spectrometry experiment, we used the strategy mentioned above 
(Figure 3.9).  
 
Figure 3.9: The mass spectrometry experiment. 
STS-treated HeLa cells were lysed and fractionated by gel filtration using the S500 column. The 
5MDa fractions were pooled together and the complex was pulled down by anti-XIAP Ab beads. 
The control consisted of the fractions being pulled down with mouse IgG antibody. The complex 
was then eluted from the antibody with 8M urea and used for mass spectrometry. The red 
rectangle indicates the fractions containing the 5MDa complex. 
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Interestingly, three of the proteins (Herc2, Neurl4 and SSSCA1) have been shown to form a 
complex with each other. However, Herc2, Neurl4 and SSSCA1 have not been previously shown 
to interact with XIAP, suggesting this is a newly discovered apoptosis-dependent interaction 
(Figure 3.8 and Figure 3.9). 
 
 
Figure 3.8: Silver gel mass spectrometry results of the 5MDa complex. 
STS-treated HeLa cells were lysed and fractionated by gel filtration. The 5MDa complex was 
pulled down by anti-XIAP Ab beads, visualized and cut from a silver gel and identified by mass 
spectrometry. The color-coded arrows show the gel bands that correspond to the identified 
proteins. Herc2, SSSCA1 and Neurl4 were the most interesting proteins identified because they 
are not commonly found in mass spectrometry results and have been shown to interact with each 





Figure 3.9: In-solution mass spectrometry results of the 5MDa complex. 
STS-treated HeLa cells were lysed and fractionated by gel filtration. The 5MDa complex was 
pulled down by anti-XIAP Ab beads and identified by mass spectrometry. The red arrows point 
to proteins of interest, which have also been shown to interact with each other, but not with 
XIAP. These data are consistent with the silver gel mass spectrometry results in that Herc2, 
SSSCA1 and Neurl4 were also identified. SMAC is a mitochondrial protein that has been shown 
to bind XIAP, so it showing up in the results is not surprising. The remaining proteins are 
extremely abundant proteins that are commonly found in mass spectrometry results.  
 
Although Herc2, Neurl4 and SSSCA1 are largely uncharacterized, they were the most interesting 
candidates to us because they were the most enriched compared to the control. The enrichment of 






Co-elution of identified proteins with XIAP 
Next, we wanted to see how the gel filtration elution profiles of the identified proteins matched 
with the elution profile of XIAP. Unsurprisingly, Herc2, Neurl4 and SSSCA1 can all be found in 










Figure 3.4: Co-elution of the identified proteins with the 5MDa complex. 
STS-treated HeLa cells were lysed and fractionated by gel filtration using the Sephacryl S500 
column. Westerns of Herc2, XIAP, Neurl4 and SSSCA1 were done on the fractions to compare 
their elution profiles. Not surprisingly, Herc2, SSSCA1 and Neurl4 were all found in the 5MDa 
fractions. The elution profile of Herc2 and SSSCA1 did not change with STS treatment (data not 
shown for SSSCA1). Interestingly, upon STS treatment Neurl4 is recruited to a larger complex 
that peaks near the 5MDa fraction containing XIAP, suggesting Neurl4 and XIAP are both being 





However, what did intrigue us is that Neurl4, much like XIAP, shifts to the 5MDa fraction upon 
treatment with STS compared to untreated cells. These data suggest that Neurl4 and XIAP are 
both recruited to the same complex during apoptosis. 
Mass spectrometry of the 400kDa XIAP complex 
Under normal conditions, XIAP is not monomeric, but rather in an unknown 400kDa complex. 
This 400kDa complex does not change in response to apoptosis and appears to be a reservoir of 
XIAP. Using a similar strategy used for identifying the 5MDa complex, we also identified the 








Figure 3.10: Identification of the 400kDa XIAP complex by gel filtration. 
Under normal conditions XIAP is found in a 400kDa complex that does not change in response 
to apoptosis. We identified the proteins in this complex by mass spectrometry and discovered 
that the complex is a homo-oligomer of XIAP. The list of identified proteins on the left shows that 
XIAP is more than 20-fold enriched compared to the second-most enriched protein, suggesting 
that the complex is composed solely of XIAP. The red asterisk indicates the fraction containing 
the 5MDa complex. The red rectangle indicates the fractions containing the 400kDa XIAP 
complex. The bottom Western Blot is a lighter exposure of the upper blot. 
The mass spectrometry results of the 400kDa complex show that the complex is a homo-
oligomer of XIAP, consisting of approximately 8-9 subunits of XIAP. Interestingly, in contrast 
to the identified proteins of the 5MDa complex, SMAC was not detected in the 400kDa complex. 
Perhaps this 400kDa complex serves as an inert reservoir of XIAP that prevents XIAP from 
binding other proteins; only after XIAP is recruited away from this 400kDa is it able to interact 
with other proteins. This reservoir hypothesis suggests that the cell uses the 400kDa XIAP 
complex as a mechanism to inhibit XIAP until it is needed.  
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CHAPTER 4: CHARACTERIZING THE FUNCTIONAL SIGNIFICANCE OF THE 
COMPLEX IN APOPTOSIS 
Testing whether the knockdown of the identified proteins affects apoptosis 
Now that we have identified the constituents of the complex, we next want to investigate whether 
or not they play a functional role in apoptosis. Therefore, we want to study a timepoint in 
apoptosis where approximately 50% of the cells are apoptotic, so that we can observe if 
knocking down the identified subunits increases or decreases the number of apoptotic cells. 
Normally during apoptosis, XIAP is degraded by proapoptotic factors and auto-ubiquitination. 
ARTS, which is a proapoptotic protein and XIAP antagonist, has been shown to cause the 
degrading of XIAP after apoptosis induction. Consequently, knockdown of ARTS has shown to 
delay the degradation of XIAP during apoptosis (Edison et al. 2012). Therefore, we aimed to find 
a timepoint and concentration of STS that would result in an approximately 50% reduction in 





Figure 4.1: Western blot of STS titration in HeLa cells after 5 hours. 
HeLa cells were treated with varying amounts of STS for 5 hours. After 5 hours, the cells were 
collected and analyzed by western blot. Herc2 appears to be cleaved as apoptosis progresses, 
whereas SSSCA1 does not change. Neurl4 also does not change during apoptosis (data not 
shown). XIAP levels decrease as apoptosis progresses. Caspase 3 also gets processed into the 
active form during apoptosis. These data show that cells treated with 0.2M STS for 5 hours have 
approximately 50% of XIAP remaining, which provides a useful timepoint for testing whether 
perturbations in the complex’s subunits affect apoptosis kinetics. 
We chose to use the STS concentration of 0.2uM at 5 hours, since at that timepoint there is an 
approximately 50% reduction in XIAP levels. Next, wanted to test if knockdowns of the 
identified subunits would alter the levels of XIAP at this timepoint in apoptosis. To test this, we 
knocked down each subunit of the complex and looked how it affected the protein levels of the 







Figure 4.2: Neurl4 knockdown stabilizes XIAP in STS-treated cells. 
siRNA knockdown of the complex’s subunits in MCF7 cells with or without 0.5M STS. (a) 
Westerns of siRNA-treated cells and how the knockdowns affect the protein stability of the other 
subunits in the STS-treated cells. Neurl4 and Herc2 knockdown stabilizes XIAP during apoptosis 
compared to the control (red arrows), suggesting that the complex acts to degrade XIAP. (b) The 
same experiment repeated six times and quantified. Mean and standard error are shown (n = 6). 
P-values from t-test: ***P<0.0005, relative to the negative control.  
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Interestingly, we discovered that the knockdown of Neurl4 stabilizes XIAP during apoptosis, to 
an extent that is even greater than the XIAP stabilization that is known to occur in the ARTS 
knockdown line. Finally, counted the number of apoptotic cells for each knockdown to 
determine if apoptosis was perturbed (Figure 4.3). 
 
 
Figure 4.3: Neurl4 knockdown reduces the number of apoptotic cells. 
The complex’s subunits were knocked down in HeLa cells by siRNA. The cells were then either 
untreated or treated with 0.2uM STS for 5 hours and the total number of apoptotic cells was 
determined by counting apoptotic nuclei. Consistent with Neurl4 knockdown stabilizing XIAP 
during apoptosis, it also reduced the total number of apoptotic cells by approximately 15%. 
Intriguingly, Herc2 knockdown increased the total number of apoptotic cells, despite stabilizing 
XIAP levels. This observation is probably due to the fact that Herc2 is involved in many 
processes and its knockdown makes cells unhealthy and prone to apoptosis. The knockdown of 
Neurl4 decreasing the total number of apoptotic cells suggests that this is a proapoptotic 
complex that acts to degrade XIAP. Mean and standard error are shown (n = 3). P-values from 
t-test: *P<0.05; **P<0.005, relative to the negative control. 
The knockdown of Neurl4 resulted in a 15% reduction in the number of apoptotic cells, 
consistent with the observation that Neurl4 knockdown stabilizes XIAP during apoptosis. This 
result suggests that the complex acts as a pro-apoptotic complex that degrades XIAP during the 
initiation of apoptosis, thus increasing the propensity of the cells to undergo MOMP and commit 
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to apoptosis. However, the 15% reduction in apoptosis is quite modest, which encouraged us to 
repeat these experiments in mouse stem cells, which have been shown to be extremely sensitive 
to ARTS and XIAP. 
Shifting to a mouse model system for in vivo experiments 
As previously explained, ARTS and XIAP have been shown to have a significant role in the 
regulation of apoptosis in mouse stem cells. Therefore, we sought out to repeat the human cell 
line experiments in mouse stem cells, with the hypothesis that these cells would be more 
sensitive to the knockdown of Neurl4. We chose to use mouse hair follicle stem cells (HFSCs), 
which are responsible for maintaining hair follicles, and keratinocytes, which are stem cells 
found at the basal layer of the skin and are the main contributors to the epidermis and wound 
healing.  
Assaying apoptosis in the knockdown keratinocyte lines 
To test the effect of the knockdowns on apoptosis in keratinocytes, we used live imaging of 
caspase activity, combined with image analysis for a high throughput and accurate assay of 
apoptosis kinetics. We treated the keratinocytes with UV and quantified how many cells became 
















Figure 4.4: Neurl4 knockdown in UV and STS-treated keratinocytes reduces the number of 
apoptotic cells.  
(Top panel) Keratinocytes were treated with 200uJ of UV followed by quantification of Caspase 
3 positive cells after 0, 15 and 30 hours post-exposure. Neurl4 knockdown resulted in an 11% 
reduction in Caspase 3 positive cells compared to the control. Mean and standard deviation are 
shown (n = 3). P-values from t-test: *P<0.05. (Bottom panel) Keratinocytes were treated with 
1M staurosporine followed by quantification of Caspase 3 positive cells after 0, 15 and 30 hours. 
Neurl4 knockdown resulted in a 15% reduction in the number of Caspase 3 positive cells 
compared to the control. These data show that the reduction in apoptosis from Neurl4 
knockdown in keratinocytes is similar to the reduction seen in cultured human cell lines. Mean 
and standard deviation are shown (n = 4). P-values from t-test: **P<0.005. 
reduction in Caspase 3 positive cells compared to the control. Mean and standard deviation are 
shown (n = 3). P-values from t-test: *P<0.05. (Bottom panel) Keratinocytes were treated with 
1M staurosporine followed by quantification of Caspase 3 positive cells after 0, 15 and 30 hours. 
Neurl4 knockdown resulted in a 15% reduction in the number of Caspase 3 positive cells 
compared to the control. These data show that the reduction in apoptosis from Neurl4 
knockdown in keratinocytes is similar to the reduction seen in cultured human cell lines. Mean 
and standard deviation are shown (n = 4). P-values from t-test: **P<0.005. 
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Neurl4 knockdown in keratinocytes produced only a modest protection against apoptosis 
following UV and staurosporine treatment, similar to the results in HeLa cells. One explanation 
for the mild reduction could be that keratinocytes may not be as sensitive to the levels of ARTS 
and XIAP, and consequently Neurl4, compared to HFSCs. Another reason why the keratinocytes 
may not be very sensitive to Neurl4 knockdown could be due to the fact that the keratinocytes 
used are stable knockdown lines that have acclimated to cell culture. Culturing stem cells has 
been shown to cause reprogramming that is reminiscent of wound repair (Adam et al., 2015). 
These reprogrammed cultured stem cells may also have been selected to be resistant to apoptosis 
after growing in cell culture conditions. To address whether culturing the keratinocytes is 
causing them to lose their sensitivity to apoptosis, we could knockdown the genes in utero 
followed by FACS purifying the keratinocytes and performing the apoptosis assay on the freshly 
purified keratinocytes, before they have a chance to acclimate to cell culture. 
Using Drosophila melanogaster as a system to study the in vivo function of the complex 
Drosophila melanogaster is model organism that has been well defined over the years. Because 
our lab has extensive experience with Drosophila melanogaster, we decided to use it as a system 
to study the biological function of the complex. Specifically, we used the wing imaginal disc of 
the wandering third instar stage to study the in vivo role of the complex in apoptosis. A useful 
trait of the wing disc is that it is compartmentalized, with specific promoters driving expression 




Figure 3.11: The expression patterns in the imaginal discs of Drosophila melanogaster.  
The larva of Drosophila melanogaster contain imaginal discs that give rise to specific structures 
in the adult fly. A useful trait of the imaginal discs is the compartmentalized expression of 
specific transcription factors, which can be used to either overexpress or knockdown genes in 
their corresponding compartment and compared to the unaffected, wild-type section of the same 
imaginal disc (Beira & Paro, 2016).  
 
Using Engrailed-GAL4 coupled with UAS-EP or UAS-RNAi, we are able to either overexpress 
or knockdown genes, respectively, in the posterior compartment of the wing disc. We treated the 
wing discs with staurosporine to induce apoptosis and visualized the apoptotic cells by 
immunofluorescence using Hoechst for total DNA, anti-γ-H2Av to label phosphorylated histone 




Figure 3.12: Optimizing apoptotic markers in staurosporine-treated wing discs of Drosophila 
melanogaster. 
Imaginal wing discs from wild-type third instar larva were treated in-situ with 1M staurosporine 
for 4 hours and imaged by immunofluorescence. A late phenotypic marker of apoptosis is the 
condensation of DNA into foci (red arrows). However, before the DNA can be condensed, it is 
first cleaved, primarily by the protein CAD. The cleavage of the DNA is marked by the γ 
phosphorylation of the histone H2Av (magenta). Cleaved Caspase 3, which is the active form, is 
another indicator of apoptosis (green). Interestingly, we observed that γ-H2Av marks an earlier 
apoptotic timepoint than cleaved Caspase 3, which labels apoptotic cells the at the late timepoint 
of DNA condensation.  
 
The staining of the wing discs revealed that DNA condensation and active Caspase 3 (DrICE and 
Dcp-1 in Drosophila melanogaster) signal marked similar timepoints, whereas γ-H2Av labeled 
cells at an earlier timepoint in apoptosis. The observation that γ-H2Av labels apoptotic cells 
before active Caspase 3 is counter-intuitive because active caspases are required for CAD’s 
activation and subsequent DNA cleavage (Tang & Kidd, 1998). A possible explanation for why 
γ-H2Av labels cells before active Caspase 3 is that the anti-cleaved Caspase 3 antibody also 
labels the cleaved substrates of Caspase 3, and only after a sufficient amount of cleaved substrate 
accumulates is there enough signal for detection, which might occur later than the γ 
phosphorylation of H2Av. These data show that the γ-H2Av and cleaved Caspase 3 antibodies 
can be used to label cells at different timepoints in apoptosis. 
After validating antibodies to label apoptosis in the wing disc, we next needed to optimize the 
timing of apoptosis in the wing disc so that some, but not all cells have undergone apoptosis. To 
find a suitable timepoint, we treated wing discs in-situ with staurosporine for various timepoints; 
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Engrailed-GAL4 UAS-DsRed2 was used to label the compartment of the wing disc (posterior) 
that expresses Engrailed in red (Figure 3.13). 
 
Figure 3.11: Wing discs treated with staurosporine for various timepoints. 
Third instar imaginal wing discs were treated in-situ with 1M staurosporine for 1hr, 2hr, 3hr 
and 4 hrs and imaged by immunofluorescence. Although all staurosporine timepoints resulted in 
inducing apoptosis, the three hour timepoint produced the most consistent results. Blue = 
Hoechst; Green = anti-Cleaved Caspase 3; Red = Engrailed-GAL UAS-DsRed2; Magenta = 




The above data show that all timepoints of staurosporine treatment resulted in apoptotic cells 
compared to the untreated control. However, the three-hour treatment of staurosporine resulted in 
a more consistent number of apoptotic cells compared to the other timepoints, which had large 
variation in the number of apoptotic cells (data not shown).  
To study if the complex affects apoptosis in the wing discs, we crossed flies to either overexpress 
or knockdown Neurl4 (bluestreak or blue in the fly) under the control of Engrailed so we could 





Figure 3.11: The effect of staurosporine on wing discs that are either knocked down for or 
overexpressing Neurl4. 
Third instar wing discs were treated in-situ with 1M staurosporine for 3 hours and imaged by 
immunofluorescence. The RNAi and overexpression is under the control of the Engrailed-Gal4 
UAS system. The knockdown and overexpression of Neurl4 (Blue in the fly) was localized to the 
posterior (labeled in red) compartment of the wing disc. The anterior compartment of the wing 
disc can be used as a wild-type internal control. After treatment with staurosporine, the posterior 
compartment had higher numbers of apoptotic cells compared to the anterior compartment in all 
cases. Gal4 overexpression has been observed to induce cytotoxicity and primes the cells for 
apoptosis compared to the wild-type anterior compartment, which lacks Gal4 overexpression. 
Therefore, because Gal4 produces a high apoptosis background, this system is not suitable for 
studying how the complex affects apoptosis. The white gene served as the control for Gal4. Dark 
RNAi (Apaf1 in mammals) was used as a control for the ability to inhibit apoptosis in this 




Neurl4 (bluestreak or blue in Drosophila) was the only member of the complex that had flies 
available for RNAi and overexpression. The white gene was used as a control for Gal4 
overexpression and Dark (Apaf1 in mammals) knockdown was used as a control for the ability to 
inhibit staurosporine-induced apoptosis in this system. Dark has been well characterized in the 
fly and has been shown to be crucial for proper apoptosis, so its knockdown inhibiting apoptosis 
in this system was not surprising (Rodriguez et al., 1999). However, what immediately stood out 
to us was the fact that there were higher numbers of apoptotic cells in the Engrailed Gal4 
posterior compartment in all of the other conditions. Looking through the literature, we 
discovered that Gal4 overexpression has been observed to cause cytotoxicity (Kramer & 
Staveley, 2003). After repeating this experiment several times with the same results, we 
concluded that the Gal4 overexpression system is not suitable for studying how the complex 
affects apoptosis, since Gal4 overexpression is creating a high apoptosis background. An 
alternative approach would be to drive the knockdown and overexpression of Neurl4 using a 
different driver, such as tubulin. The appeal of using Drosophila to test the complex in vivo was 
that the tools and resources to do the experiments were readily available. However, since 
switching drivers would require us to create new fly lines from scratch, we decided it would be 
best to focus our efforts on mammalian cells, since that is where we have established the 





CHAPTER 5. DISCUSSION 
We sought out to understand what accounts for the variability of apoptosis kinetics between 
cells. Since apoptosis becomes robust and predictable following MOMP, it was obvious to us 
that the cause of the variance must be very early in apoptosis, upstream of MOMP. Looking for 
changes in canonical apoptosis proteins at early timepoints, we discovered that XIAP is recruited 
to a 5MDa complex as early as 30 minutes after induction of apoptosis, and that this recruitment 
of XIAP to the complex is dependent on ARTS. We identified the subunits of the complex being 
Herc2, Neurl4, SSSCA1 and XIAP. Furthermore, we showed that the complex acts to degrade 
XIAP and priming the cells to die, because when Neurl4 is knocked down, XIAP becomes 




Figure 5.1: The postulated model of how the complex recruits and degrades XIAP. 
Under normal conditions XIAP is found in an inert 400kDa complex. However, upon apoptosis 
induction, ARTS recruits XIAP to the 5MDa complex, where XIAP is ubiquitinated and 
degraded, thus priming cells to die. 
 
However, after only seeing a 15% reduction in apoptosis in the human cell lines, we 
hypothesized that we would observe a more pronounced effect in mouse stem cells, since 
previous studies have shown XIAP and ARTS playing a pivotal role in regular apoptosis in these 
cells. Disappointingly, we saw similar results for the mouse stem cells.  
A likely explanation for why the results were similar is that the process of cells adapting to the 
cell culture environment reprograms the cells, making them more resistant to apoptosis 
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compared to their in vivo counterparts. There is a recent study supporting this idea, which shows 
that stem cells that are taken out of their in vivo environment and put into cell culture 
immediately undergo reprogramming that is very reminiscent of a wound healing profile (Figure 
5.2; (Adam et al., 2015)).  
 
Figure 5.2: Stem cells undergo extensive reprogramming when removed from their in-vivo niche 
and put into culture. 
The left panel shows that many signature stem cell transcription factors are down-regulated 
when the stem cells are put into culture. Many wound repair genes, such as Macf1, are also 
upregulated in cultured stem cells. If the cell culture environment is harsh and reminiscent of a 
wound, then perhaps this could explain why cells that survive in culture are resistant to 
apoptosis compared to their in-vivo counterparts (Adam et al., 2015). 
 
In addition, it has been shown that mouse HFSCs are extremely susceptible to apoptotic stimuli 
when they are freshly sorted and immediately assays before they are allowed to undergo 




Figure 5.2: Apoptosis in freshly sorted HFSCs is dependent on ARTS. 
Mouse HFSCs freshly sorted and immediately treated with STS or ETO and quantified for 
Caspase 3 positive cells by flow cytometry. Unlike most cultured cell lines, apoptosis in HFSCs 
is extremely sensitive the knockout of ARTS. This study highlights the particular importance of 
ARTS in stem cell homeostasis (Fuchs et al., 2013).  
 
Looking forward, the best approach to studying apoptosis in stem cells appears to be in vivo, 
since the cells seem to lose their sensitivity to apoptosis after acclimating to cell culture. 
Fortunately, there are myriad methods for studying apoptosis in an in vivo model system. One 
way is to do all of the assays with freshly sorted stem cells before they have time to reprogram. 
Wound healing of the skin is another powerful model system for studying stem cell apoptosis in 
vivo. Nonetheless, the discovery of this novel 5MDa complex is exciting. The discovery has 
implicated new players in apoptosis, it gives insight into the decision-making mechanism cells 
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undergo before committing to cell death, and provides potential for new therapeutics to be 
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